Sleep Medicine
Volume 10, Issue 3 , Pages 295-305 , March 2009

Assessing health-related quality of life in patients with restless legs syndrome

  • Svenja Happe

      Affiliations

    • Department of Clinical Neurophysiology, Klinikum Bremen-Ost, Bremen, Germany
    • Department of Clinical Neurophysiology, University of Göttingen, Germany
    • Both authors contributed equally.
    • ,
  • Jens Peter Reese

      Affiliations

    • Department of Neurology, Philipps-University Marburg, Germany
    • Both authors contributed equally.
    • ,
  • Karin Stiasny-Kolster

      Affiliations

    • Department of Neurology, Philipps-University Marburg, Germany
    • ,
  • Ines Peglau

      Affiliations

    • Private Neurological Practice, Berlin
    • ,
  • Geert Mayer

      Affiliations

    • Department of Neurology, Hephata Klinik, Schwalmstadt-Treysa, Germany
    • ,
  • Jens Klotsche

      Affiliations

    • Department of Clinicial Psychology and Psychotherapy, Technical University Dresden, Germany
    • ,
  • Guido Giani

      Affiliations

    • Department of Biometrics and Epidemiology, Heinrich-Heine-University, Düsseldorf, Germany
    • ,
  • Max Geraedts

      Affiliations

    • School of Public Health, Heinrich-Heine-University, Düsseldorf, Germany
    • ,
  • Claudia Trenkwalder

      Affiliations

    • Department of Clinical Neurophysiology, University of Göttingen, Germany
    • Paracelsus-Elena-Klinik, Kassel, Germany
    • ,
  • Richard Dodel

      Affiliations

    • Department of Neurology, Philipps-University Marburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6421 2866251; fax: +49 6421 2868955.

Received 13 July 2007 ,Revised 28 December 2007 ,Accepted 5 January 2008.

References 

  1. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev. 2006;10:153–167
  2. Milligan SA, Chesson AL. Restless legs syndrome in the older adult: diagnosis and management. Drugs Aging. 2002;19:741–751
  3. Reuther M, Spottke EA, Klotsche J, et al. Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord. 2007;13:108–114
  4. Schrag A, Jahanshahi M, Quinn N. How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15:1112–1118
  5. Haacke C, Althaus A, Spottke A, Siebert U, Back T, Dodel R. Long-term outcome after stroke: evaluating health-related quality of life using utility measurements. Stroke. 2006;37:193–198
  6. Gottberg K, Einarsson U, Ytterberg C, et al. Health-related quality of life in a population-based sample of people with multiple sclerosis in stockholm county. Mult Scler. 2006;12:605–612
  7. Greiner W, Claes C, Busschbach JJ, Graf von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2004;6(2):124–130
  8. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119
  9. Walters AS, LeBrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132
  10. Hays RD, Stewart AL. Sleep measures. Durham and London: Duke University Press; 1992;
  11. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the medical outcomes study sleep measure. Sleep Med. 2005;6:41–44
  12. Richter P, Werner J, Bastine R, Heerlein A, Kick H, Sauer H. Measuring treatment outcome by the beck depression inventory. Psychopathology. 1997;30:234–240
  13. Greiner W. Die Berechnung von Kosten und Nutzen im Gesundheitswesen. In:  Schöffski O,  Schulenburg JM editor. Gesundheitsökonomische Evaluationen. Hamburg: Springer; 2000;
  14. Statistisches Bundesamt. Statistisches Jahrbuch für die Bundesrepublik Deutschland 2006. Berlin: Statistisches Bundesamt, 2006.
  15. Oertel WH, Trenkwalder C, Zucconi M, et al. State of the art in restless legs syndrome therapy. Practice recommendations for treating restless legs syndrome. Mov Disord. 2007;22:207–212
  16. Reese JP, Stiasny-Kolster K, Oertel WH, Dodel RC. Health-related quality of life and economic burden in patients with restless legs syndrome. Expert Rev Pharmacoeconomics Outcomes Res. 2007;5:503–521
  17. König HH, Bernert S, Angermeyer MC. Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen. 2005;67:173–182
  18. Gerhard R, Bosse A, Uzun D, Orth M, Kotterba S. Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue. Med Klin (Munich). 2005;100:704–709
  19. Kushida C, Martin M, Nikam P, et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res. 2007;16(4):617–624
  20. Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26:925–935
  21. Dodel R, Peter H, Spottke A, et al. Health-related quality of life in patients with narcolepsy. Sleep Med. 2007;8(7-8):733–741
  22. McCrink L, Allen RP, Wolowacz S, Sherrill B, Connolly M, Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med. 2007;8:73–83
  23. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;28:891–898
  24. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology. 2000;54:1064–1068
  25. Sukegawa T, Itoga M, Seno H, et al. Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci. 2003;57:265–270
  26. Addington AM, Gallo JJ, Ford DE, Eaton WW. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981–1994. Psychol Med. 2001;31:1037–1044
  27. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411–418
  28. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins precursors study. Am J Epidemiol. 1997;146:105–114
  29. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. Jama. 1989;262:1479–1484
  30. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159–1163
  31. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Sleep Med. 2000;1:221–229
  32. Oertel WH, Benes H, Garcia-Borreguero D, et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2007;in press.
  33. Kohnen R, Benes H, Kurella B. Development of the disease-specific restless legs syndrome quality of life (RLS-QoL) questionnaire. Mov Disord. 2002;17:P743
  34. Kohnen R, Allen RP, Benes H, et al. Assessment of restless legs syndrome – Methodological approaches for use in practice and clinical trials. Mov Disord. 2007;22(Suppl. 18):S485–S94
  35. Trenkwalder C, Benes H, Grote L, et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. Mov Disord. 2007;22:696–703
  36. Oertel WH, Benes H, Bodenschatz R, et al. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). Neurology. 2006;67:1040–1046
  37. Atkinson MJ, Allen RP, DuChane J, Murray C, Kushida C, Roth T. Validation of the restless legs syndrome quality of life instrument (RLS-QLI): findings of a consortium of national experts and the RLS foundation. Qual Life Res. 2004;13:679–693
  38. Abetz L, Vallow SM, Kirsch J, Allen RP, Washburn T, Earley CJ. Validation of the restless legs syndrome quality of life questionnaire. Value Health. 2005;8:157–167
  39. Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord. 2006;21:1404–1410
  40. Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006;67:1034–1039
  41. Montplaisir J, Karrasch J, Haan J, Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord. 2006;21:1627–1635
  42. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414–1423
  43. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75:92–97
  44. Kushida C, Martin M, Nikam P, et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res. 2007;16:617–624
  45. Gerhard R, Bosse A, Uzun D, Orth M, Kotterba S. Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue. Med Klin (Munich). 2005;100:704–709
  46. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–1292
  47. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202
  48. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237–246
  49. Winkelman JW, Eckardt KM, Müller-Myshok B, Gasser T. The Restless Legs Syndrome - A Genetic View of the Disease. Das Restless Legs Syndrom aus genetischer Sicht. Somnologie. 2002;6(1):3–6

PII: S1389-9457(08)00011-7

doi: 10.1016/j.sleep.2008.01.002

Sleep Medicine
Volume 10, Issue 3 , Pages 295-305 , March 2009

Article Tools

* Image Usage & Resolution